The co-CEO’s of the FemTech Association Asia discuss democratizing women’s health and the investment opportunities in Asia.    The latest episode of Voices of Biotech, produced by the Bioprocess Insider Expression Platform, brings you a conversation between the two co-CEO’s of the FemTech Association of Asia. This initiative was founded by Lindsay Davis, co-CEO, in 2021 and is Asia’s first and largest network for organizations and investors in FemTech. The association has over 135 members and 60 start-ups, across nine countries in Asia. Davis…

The three founders of the CGT Circle discuss the importance of decentralized networking for women and why the network was created. In the latest episode of Voices of Biotech, brought to you by the BioProcess Insider Expression Platform, editor of BioProcess Insider Mille Nelson sits down with the three founding members of the CGT Circle. They discuss the demand for local community led networking, leading them to launch their platform which aims to create “decentralized networking” for women in the…

“We want to see women ascending leadership positions and that will be our metric of success,” says Lara Silverman, principal consultant at LIS BioConsulting on the latest Voices of Biotech podcast. In the latest Voices of Biotech podcast, brought to you by the BioProcess Insider Expression Platform, Lara Silverman sheds some light on career paths, mentorship, and taking ownership of your own development. Silverman discusses DE&I in the cell and gene therapy space, emphasising the goal is to get to…

Terumo’s CEO Antoinette Gawin discusses women in the life sciences space, historical bias in the industry, and the importance of hearing every voice in the workplace, no matter who it is coming from. This episode of the Voices of Biotech – brought to you by the BioProcess Insider Expression Platform -brings you an in-depth conversation with Antoinette Gawin, CEO of Terumo Blood and Cell Technologies. Gawin shares her personal experience of growing up within an immigrant farming community before entering the…

“Women and people of diverse backgrounds remain underrepresented in the upper echelons of the biopharma C-suite,” says Ilona Gutcher, director of BD&L Oncology at Bayer. Aligning with International Women’s Day (Wednesday 8th March) the BioProcess Insider Expression Platform has released its second episode of Voices of Biotech. “I wouldn’t be here without the I&D Xcelerate program,” says Gutcher, another graduate of the Bayer program launched by Marianne De backer two years ago to promote diversity through a 6–9 month placement…

Deepa Talpade discusses how women can reach their full potential in life sciences through schemes like Bayer’s I&D Xcelerate program in the first episode of our Voices of Biotech podcast. Concurrent with International Day of Women and Girls in Science (Friday 10 February), the BioProcess Insider Expression Platform has launched Voices of Biotech – a podcast that celebrates women and minorities in science and what more can be done to amplify their voices. Despite the progress over the last decade,…

We sit down with Ori Biotech’s CEO Jason Foster to discuss the company’s paperless platform journey to commercialization and to delve deep into the challenges associated with accessing advanced therapies. This episode of the BioProcess Insider Expression Platform (BIEP) podcast brings you an in-depth conversation with Jason Foster, CEO of Ori Biotech. The company experienced a year of transition in 2022 with the closing of its $100 million Series B funding round and the expansion of its paperless cell and…

The latest edition of the BioProcess Insider Expression Platform has NIBRT’s Killian O’Driscoll speaking on Ireland’s robust biomanufacturing environment, training programs, and vendor-led technologies. Ireland has long established itself as a drug manufacturing hub and is home to commercial production sites run by Big Pharma firms including Pfizer, J&J, Eli Lilly, and AstraZeneca, as well as numerous third-party manufacturing organizations and bioprocess vendor firms. The country has evolved to mirror industry’s shift from small molecule to large molecule, and now…

With expertise in development and CMC in short supply globally, CDMO choice is absolutely critical for sponsors relying on them to accelerate development pathway, says Pharmatech Associates. Ahead of November’s CPhI Worldwide event in Frankfurt, Germany, BioProcess Insider hosted a LinkedIn Live discussion with Bikash Chatterjee and Stephanie Gaulding, the respective CEO and MD at drug development consultancy firm Pharmatech Associates about current outsourcing strategies and how to go about selecting a CDMO partner. Listen to the full discussion, as…